What mediates the benefits associated with dipeptidyl peptidase-IV inhibition?
(2005) In Diabetologia 48. p.605-607
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/134929
- author
- Ahrén, Bo LU
- organization
- publishing date
- 2005
- type
- Contribution to journal
- publication status
- published
- subject
- in
- Diabetologia
- volume
- 48
- pages
- 605 - 607
- publisher
- Springer
- external identifiers
-
- wos:000228515900001
- scopus:17844381917
- ISSN
- 1432-0428
- DOI
- 10.1007/s00125-005-1706-6
- language
- English
- LU publication?
- yes
- id
- fad0dd2f-354a-4d2b-821b-839890c395ff (old id 134929)
- alternative location
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15770467&dopt=Abstract
- date added to LUP
- 2016-04-01 12:03:35
- date last changed
- 2024-02-23 17:22:57
@article{fad0dd2f-354a-4d2b-821b-839890c395ff,
author = {{Ahrén, Bo}},
issn = {{1432-0428}},
language = {{eng}},
pages = {{605--607}},
publisher = {{Springer}},
series = {{Diabetologia}},
title = {{What mediates the benefits associated with dipeptidyl peptidase-IV inhibition?}},
url = {{http://dx.doi.org/10.1007/s00125-005-1706-6}},
doi = {{10.1007/s00125-005-1706-6}},
volume = {{48}},
year = {{2005}},
}